Warmi
Warmi, licence 80097151: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Herbal hormonal replacement therapy
- Licence holder
- Vitac Pharmaceutical Canada Inc.
- NPN or DIN-HM
- 80097151
- Status
- Active licence
- Licence date
- 18 February 2020
- Revision date
- 25 January 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bioflavonoïdes d'agrumes Source : Citrus aurantium - Pelure de fruit | 10.0 mg | Not calculated |
| Lepidium meyenii Source : Hypocotyle Extract : Matériel brut sec Extraction ratio : 2.3:1 Dry plant equivalent : 1150 mg | 500.0 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropyl méthylcellulose, Eau purifiée, Sorbitol, Stéarate de magnésium, Dioxyde de silicium colloïdal, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Help support health mood balance during menopause and emotional aspects of sexual health. Provides antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have high blood pressure. Consult a health care professional prior to use if you are pregnant of breastfeeding. Consult a health care practitioner prior to use if you are taking antidepressants or blood thinners. Consult a health care practitioner prior to use if you suffer from any psychological disorder and/or condition such as frequent anxiety or depression.
Source
Official Health Canada record, licence 80097151
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.